Dr. Hopkins is board-certified in internal medicine and infectious disease and has held clinical and product development positions over 30 years at FDA, Merck, Aeras, BARDA and multiple biotech companies. Prior to Tolka AI Therapeutics, Dr. Hopkins was the Chief Medical Officer at Adaptive Phage Therapeutics and Ocugen, where he led clinical development and medical affairs activities. He has approved multiple therapeutic and prophylactic products in the infectious disease space. He is passionate about finding solutions to difficult-to-treat infections, including those due to non-tuberculous mycobacteria (NTM) and M. tuberculosis (TB).
